ORPHA — Orphazyme A/S Cashflow Statement
0.000.00%
Last trade - 00:00
- DKK36.97m
- DKK25.70m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -336 | -633 | -627 | -41.2 | -27 |
Depreciation | |||||
Non-Cash Items | 2.55 | 52.8 | 9.25 | -76.5 | 0 |
Discontinued Operations | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.78 | 36.2 | -3.4 | -1.99 | 7.02 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -327 | -539 | -603 | -118 | -20 |
Capital Expenditures | -3.29 | -5.1 | -0.994 | 0 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 1.04 | 90.3 | -6.94 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -3.29 | -5.1 | 0.046 | 90.3 | -6.94 |
Financing Cash Flow Items | — | -108 | 0 | -0.141 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 58.9 | 1,159 | -30.3 | -35.1 | -0.685 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -271 | 603 | -625 | -65.6 | -27.6 |